Cirrhosis

Surgical Pathology of the GI Tract, Liver, Biliary Tract and Pancreas

Volumn , Issue , 2009, Pages 1115-1145

  Wanless, Ian R ^a,b   Crawford, James M ^c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 72949096166     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-141604059-0.50045-X     Document Type: Chapter

References (134)

1. Miniño AM, Heron M, Smith B Deaths: Preliminary data for 2004. Natl Vital Stat Rep 2006, 54:1-50.
2. Foreman MG, Mannino DM, Moss M Cirrhosis as a risk factor for sepsis and death: Analysis of the National Hospital Discharge Survey. Chest 2003, 124:1016-1020.
3. Schubert GE, Bethke-Bedurftig BA, Bujnoch AW, Diem A [Liver cirrhosis in autopsy material within 48 years: I. Changes of prevalence, regional differences (author's translation)]. Z Gastroenterol 1982, 20:213-220.
4. Melato M, Sasso F, Zanconati F Liver cirrhosis and liver cancer: A study of their relationship in 2563 autopsies. Zentralbl Pathol 1993, 139:25-30.
5. Cortes-Espinosa T, Mondragon-Sanchez R, Hurtado-Andrade H, Sanchez-Cisneros R Hepatocellular carcinoma and hepatic cirrhosis in Mexico: A 25-year necroscopy review. Hepatogastroenterology 1997, 44:1401-1403.
6. Anthony PP, Ishak KG, Nayak NC, et al. The morphology of cirrhosis: Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol 1978, 31:395-414.
7. Crawford JM Basic mechanisms in hepatopathology. MacSween's Pathology of the Liver 2007, 75-9883. Elsevier Churchill-Livingstone, Edinburgh. 5th ed. A.D. Burt, B.C. Portmann, L. Ferrell (Eds.).
8. Wanless IR Vascular disorders. MacSween's Pathology of the Liver 2007, 613-9352. Elsevier Churchill-Livingstone, Edinburgh. 5th ed. A.D. Burt, B.C. Portmann, L. Ferrell (Eds.).
9. Wanless IR Pathogenesis of cirrhosis: The role of hemodynamic forces causing in-out-imbalance and congestive injury (congestive hepatopathy). Histopathology 2008, in press.
10. Friedman SL, Rockey DC, Bissell DM Hepatic fibrosis 2006: Report of the Third AASLD Single Topic Conference. Hepatology 2007, 45:242-249.
11. Iredale JP Models of liver fibrosis: Exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 2007, 117:539-548.
12. Murata K, Ochiai Y, Akashio K Polydispersity of acidic glycosaminoglycan components in human liver and the changes at different stages in liver cirrhosis. Gastroenterology 1985, 89:1248-1257.
13. James J, Bosch KS, Zuyderhoudt FM, et al. Histophotometric estimation of volume density of collagen as an indication of fibrosis in rat liver. Histochemistry 1986, 85:129-133.
14. Ramadori G, Saile B Portal tract fibrogenesis in the liver. Lab Invest 2004, 84:153-159.
15. Clouston AD, Powell EE, Walsh MJ, et al. Fibrosis correlates with a ductular reaction in hepatitis C: Roles of impaired replication, progenitor cells and steatosis. Hepatology 2005, 41:809-818.
16. Guyot C, Lepreux S, Combe C, et al. Hepatic fibrosis and cirrhosis: The (myo)fibroblastic cell subpopulations involved. Int J Biochem Cell Biol 2006, 38:135-151.
17. Iredale JP Hepatic stellate cell behavior during resolution of liver injury. Semin Liver Dis 2001, 21:427-436.
18. Herrick FC An experimental study into the cause of the increased portal pressure in portal cirrhosis. J Exp Med 1907, 9:93-104.
19. Moschcowitz E Morphology and pathogenesis of biliary cirrhosis. AMA Arch Pathol 1952, 54:259-275.
20. Schaffner F, Popper H Capillarization of the hepatic sinusoids in man. Gastroenterology 1963, 4:239-242.
21. Mori T, Okanoue T, Sawa Y, et al. Defenestration of the sinusoidal endothelial cell in a rat model of cirrhosis. Hepatology 1993, 17:891-897.
22. Martinez-Hernandez A, Martinez J The role of capillarization in hepatic failure: Studies in carbon tetrachloride-induced cirrhosis. Hepatology 1991, 14:864-874.
23. Mastai R, Laganiere S, Wanless IR, et al. Hepatic sinusoidal fibrosis induced by cholesterol and stilbestrol in the rabbit: 2. Hemodynamic and drug disposition studies. Hepatology 1996, 24:865-870.
24. Le Couteur DG, Fraser R, Hilmer S, et al. The hepatic sinusoid in aging and cirrhosis: Effects on hepatic substrate disposition and drug clearance. Clin Pharmacokinet 2005, 44:187-200.
25. Sherman IA, Pappas SC, Fisher MM Hepatic microvascular changes associated with development of liver fibrosis and cirrhosis. Am J Physiol 1990, 258:H460-H465.
26. Wanless IR, Wong F, Blendis LM, et al. Hepatic and portal vein thrombosis in cirrhosis: Possible role in development of parenchymal extinction and portal hypertension. Hepatology 1995, 21:1238-1247.
27. Wanless IR, Shimamatsu K Phlebitis in viral and auto-immune chronic hepatitis and primary biliary cirrhosis: Possible role in the histogenesis of cirrhosis. Mod Pathol 1997, 10:147A.
28. Wanless IR, Shiota K The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: A four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis. Semin Liver Dis 2004, 24:99-106.
29. Halliday P Development of the postthrombotic syndrome: Its management at different stages. World J Surg 1990, 14:703-710.
30. Bonsib SM Glomerular basement membrane necrosis and crescent organization. Kidney Int 1988, 33:966-974.
31. Hewitson TD, Martic M, Kelynack KJ, et al. Thrombin is a pro-fibrotic factor for rat renal fibroblasts in vitro. Nephron Exp Nephrol 2005, 101:e42-e49.
32. Vesey DA, Cheung CW, Kruger WA, et al. Thrombin stimulates proinflammatory and proliferative responses in primary cultures of human proximal tubule cells. Kidney Int 2005, 67:1315-1329.
33. Remacle M, Degols JC, Delos M Exudative lesions of Reinke's space: An anatomicopathological correlation. Acta Otorhinolaryngol Belg 1996, 50:253-264.
34. Schnells G, Voigt WH, Redl H, et al. Electron-microscopic investigation of lung biopsies in patients with post-traumatic respiratory insufficiency. Acta Chir Scand Suppl 1980, 499:9-20.
35. Slauson DO, Hahn FF, Benjamin SA, et al. Inflammatory sequences in acute pulmonary radiation injury. Am J Pathol 1976, 82:549-572.
36. Damiano VV, Cherian PV, Frankel FR, et al. Intraluminal fibrosis induced unilaterally by lobar instillation of CdCl2 into the rat lung. Am J Pathol 1990, 137:883-894.
37. Wanless IR An hypothesis for the pathogenesis of cirrhosis based on vascular pathology of liver in pre-cirrhotic states. Mod Pathol 1994, 7:136A.
38. Galani S, Blonid L, Li Bssi S, et al. Prevalence of spontaneous hepatofugal portal flow in liver cirrhosis: Clinical and endoscopic correlation in 228 patients. Gastroenterology 1991, 100:160-167.
39. Hou PC, McFadzean AJS Thrombosis and intimal thickening in the portal system in cirrhosis of the liver. J Pathol Bacteriol 1965, 89:473-480.
40. Goodman ZD, Ishak KG Occlusive venous lesions in alcoholic liver disease: A study of 200 cases. Gastroenterology 1982, 83:786-796.
41. Nakanuma Y, Ohta G, Doishita K Quantitation and serial section observations of focal veno-occlusive lesions of hepatic veins in liver cirrhosis. Virchows Arch (Pathol Anat) 1985, 405:429-438.
42. Burt AD, MacSween RNM Hepatic vein lesions in alcoholic liver disease: Retrospective biopsy and necropsy study. J Clin Pathol 1986, 39:63-67.
43. Rubin EM, Martin AA, Thung SN, Gerber MA Morphometric and immunohistochemical characterization of human liver regeneration. Am J Pathol 1995, 147:397-404.
44. Falkowski O, An HJ, Ianus IA, et al. Regeneration of hepatocyte "buds" in cirrhosis from intrabiliary stem cells. J Hepatol 2003, 39:357-364.
45. Santoni-Rugiu E, Jelnes P, Thorgeirsson SS, Bisgaard HC Progenitor cells in liver regeneration: Molecular responses controlling their activation and expansion. APMIS 2005, 113:876-902.
46. Ross MA, Sander CM, Kleeb TB, et al. Spatiotemporal expression of angiogenesis growth factor receptors during the revascularization of regenerating rat liver. Hepatology 2001, 34:1135-1148.
47. Masuko K, Rubin E, Popper H Proliferation of bile ducts in cirrhosis. Arch Pathol Lab Med 1964, 78:421-431.
48. Crosby HA, Hubscher S, Fabris L, et al. Immunolocalization of putative human liver progenitor cells in livers from patients with end-stage primary biliary cirrhosis and sclerosing cholangitis using the monoclonal antibody OV-6. Am J Pathol 1998, 152:771-779.
49. Theise ND, Saxena R, Portmann BC, et al. The canals of Hering and hepatic stem cells in humans. Hepatology 1999, 30:1425-1433.
50. Kossor DC, Meunier PC, Dulik DM, et al. Bile duct obstruction is not a prerequisite for type 1 biliary epithelial cell hyperplasia. Toxicol Appl Pharmacol 1998, 152:327-338.
51. Wanless IR, Nakashima E, Sherman M Regression of human cirrhosis: Morphologic features and the genesis of incomplete septal cirrhosis. Arch Pathol Lab Med 2000, 124:1599-1607.
52. Perez-Tamayo R Cirrhosis of the liver: A reversible disease?. Pathol Annu 1979, 14:183-213.
53. Abdel-Aziz G, Lebeau G, Rescan PY, et al. Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat. Am J Pathol 1990, 137:1333-1342.
54. Dunn MA, Cheever AW, Paglia LM, et al. Reversal of advanced liver fibrosis in rabbits with schistosomiasis japonica. Am J Trop Med Hyg 1994, 50:499-505.
55. Dufour JF, DeLellis R, Kaplan MM Reversibility of hepatic fibrosis in autoimmune hepatitis. Ann Intern Med 1997, 127:981-985.
56. Villeneuve JP, Condreay LD, Willems B, et al. Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B. Hepatology 2000, 31:207-210.
57. Pol S, Carnot F, Nalpas B, et al. Reversibility of hepatitis C virus-related cirrhosis. Hum Pathol 2004, 35:107-112.
58. Friedman SL, Bansal MB Reversal of hepatic fibrosis-fact or fantasy?. Hepatology 2006, 43:S82-S88.
59. Bortolotti F, Guido M Reversal of liver cirrhosis: A desirable clinical outcome and its pathogenic background. J Pediatr Gastroenterol Nutr 2007, 44:401-406.
60. Arthur MJ, Mann DA, Iredale JP Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis. J Gastroenterol Hepatol 1998, 13(Suppl):S33-S38.
61. Shimamatsu K, Wanless IR Role of ischemia in causing apoptosis, atrophy, and nodular hyperplasia in human liver. Hepatology 1997, 26:343-350.
62. Ward NL, Haninec AL, Van Slyke P, et al. Angiopoietin-1 causes reversible degradation of the portal microcirculation in mice: Implications for treatment of liver disease. Am J Pathol 2004, 165:889-899.
63. Leevy CM, Popper H, Sherlock S Diseases of the Liver and Biliary Tract: Standardization of Nomenclature, Diagnostic Criteria, and Diagnostic Methodology (Report of the Fogarty Conference) 1976, 17-982. Year Book Medical Publishers, Chicago.
64. Anthony PP, Ishak KG, Nayak NC, et al. The morphology of cirrhosis: Definition, nomenclature, and classification. Bull WHO 1977, 4:521-540.
65. Shimamatsu K, Kage M, Nakashima O, Kojiro M Pathomorphological study of HCV-antibody positive liver cirrhosis. J Gastroenterol Hepatol 2004, 9:624-630.
66. Fauerholdt L, Schlichting P, Christensen E, et al. Conversion of micronodular cirrhosis into macronodular cirrhosis. Hepatology 1983, 3:928-931.
67. Wanless IR, Shimamatsu K The histogenesis of biliary cirrhosis. Mod Pathol 1999, 12:169A.
68. Popper H Pathologic aspects of cirrhosis. Am J Pathol 1977, 87:228-264.
69. Rappaport AM, MacPhee PJ, Fisher MM, Phillips MJ The scarring of the liver acini (cirrhosis): Tridimensional and microcirculatory considerations. Virchows Arch A Pathol Anat Histopathol 1983, 402:107-137.
70. Picchiotti R, Mingazzini PL, Scucchi L, et al. Correlations between sinusoidal pressure and liver morphology in cirrhosis. J Hepatol 1994, 20:364-369.
71. Sciot R, Staessen D, Van Damme B, et al. Incomplete septal cirrhosis: Histopathological aspects. Histopathology 1988, 13:593-603.
72. Nevens F, Staessen D, Sciot R, et al. Clinical aspects of incomplete septal cirrhosis in comparison with macronodular cirrhosis. Gastroenterology 1994, 106:459-463.
73. Gall EA Posthepatitic, postnecrotic, and nutritional cirrhosis: A pathologic analysis. Am J Pathol 1960, 36:241-258.
74. Meindok H, Langer B Liver scan in Budd-Chiari syndrome. J Nucl Med 1976, 17:365-368.
75. Benz EJ, Baggenstoss AH, Wollaeger EE Atrophy of the left lobe of the liver. Arch Pathol 1952, 53:315-330.
76. Theise ND, Schwartz M, Miller C, Thung SN Macroregenerative nodules and hepatocellular carcinoma in forty-four sequential adult liver explants with cirrhosis. Hepatology 1992, 16:949-955.
77. International Working Party Terminology of nodular hepatocellular lesions. Hepatology 1995, 22:983-993.
78. Qizilbash A, Kontozoglou T, Sianos J, Scully K Hepar lobatum associated with chemotherapy and metastatic breast cancer. Arch Pathol Lab Med 1987, 111:58-61.
79. Belli L, Sansalone CV, Aseni P, et al. Portal thrombosis in cirrhosis: A retrospective analysis. Ann Surg 1986, 302:286-291.
80. Bertelli R, Nardo B, Montalti R, et al. Liver transplantation in recipients with portal vein thrombosis: Experience of a single transplant center. Transplant Proc 2005, 37:1119-1121.
81. Amitrano L, Guardascione MA, Brancaccio V, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 2004, 40:736-741.
82. Pirisi M, Avellini C, Fabris C, et al. Portal vein thrombosis in hepatocellular carcinoma: Age and sex distribution in an autopsy study. J Cancer Res Clin Oncol 1998, 124:397-400.
83. Uenishi T, Hirohashi K, Haba T, et al. Portal thrombosis due to intrahepatic cholangiocarcinoma following successful treatment for hepatocellular carcinoma. Hepatogastroenterology 2003, 50:1140-1142.
84. Schabel SI, Rittenberg GM, Javid LH, et al. The "bull's-eye" falciform ligament: A sonographic finding of portal hypertension. Radiology 1980, 136:157-159.
85. Lafortune M, Constantin A, Breton G, et al. The recanalized umbilical vein in portal hypertension: A myth. AJR Am J Roentgenol 1985, 144:549-553.
86. Wanless IR, Bernier V Fibrous thickening of the splenic capsule: A response to chronic splenic congestion. Arch Pathol Lab Med 1983, 107:595-599.
87. Ryoo JW, Buschmann RJ Comparison of intralobar non-parenchyma, subcapsular non-parenchyma, and liver capsule thickness. J Clin Pathol 1989, 42:740-744.
88. Brunt EM Alcoholic and nonalcoholic steatohepatitis. Clin Liver Dis 2002, 6:399-420. vii,.
89. Diehl AM, Goodman Z, Ishak KG Alcohol-like liver disease in nonalcoholics: A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 1988, 95:1056-1062.
90. Teli MR, James OF, Burt AD, et al. The natural history of nonalcoholic fatty liver: A follow-up study. Hepatology 1995, 22:1714-1719.
91. Li MK, Crawford JM Pathology of cholestasis. Semin Liver Dis 2004, 24:21-42.
92. Ludwig J The pathology of primary biliary cirrhosis and autoimmune cholangitis. Baillieres Best Pract Res Clin Gastroenterol 2000, 14:601-613.
93. Raweily EA, Gibson AA, Burt AD Abnormalities of intrahepatic bile ducts in extrahepatic biliary atresia. Histopathology 1990, 17:521-527.
94. Desmet VJ Congenital diseases of intrahepatic bile ducts: Variations on the theme "ductal plate malformation. rdquo; Hepatology 1992, 16:1069-1083.
95. Crawford JM Development of the intrahepatic biliary tree. Semin Liver Dis 2002, 22:213-226.
96. Tan CE, Davenport M, Driver M, Howard ER Does the morphology of the extrahepatic biliary remnants in biliary atresia influence survival? A review of 205 cases. J Pediatr Surg 1994, 29:1459-1464.
97. Low Y, Vijayan V, Tan CE The prognostic value of ductal plate malformation and other histologic parameters in biliary atresia: An immunohistochemical study. J Pediatr 2001, 139:320-322.
98. Feigelson J, Anagnostopoulos C, Poquet M, et al. Liver cirrhosis in cystic fibrosis-therapeutic implications and long-term follow-up. Arch Dis Child 1993, 68:653-657.
99. Vawter GF, Shwachman H Cystic fibrosis in adults: An autopsy study. Pathol Annu 1979, 14(pt 2):357-382.
100. Hultcrantz R, Mengarelli S, Strandvik B Morphological findings in the liver of children with cystic fibrosis: A light and electron microscopical study. Hepatology 1986, 6:881-889.
101. Andrews NC Metal transporters and disease. Curr Opin Chem Biol 2002, 6:181-186.
102. Aaseth J, Flaten TP, Andersen O Hereditary iron and copper deposition: Diagnostics, pathogenesis and therapeutics. Scand J Gastroenterol 2007, 42:673-681.
103. Britton RS, Fleming RE, Parkkila S, et al. Pathogenesis of hereditary hemochromatosis: Genetics and beyond. Semin Gastrointest Dis 2002, 13:68-79.
104. Lombard CM, Strauchen JA Postshunt hemochromatosis with cardiomyopathy. Hum Pathol 1981, 12:1149-1151.
105. Adams PC, Bradley C, Frei JV Hepatic iron and zinc concentrations after portacaval shunting for nonalcoholic cirrhosis. Hepatology 1994, 19:101-105.
106. Loréal O, Deugnier Y, Moirand R, et al. Liver fibrosis in genetic hemochromatosis: Respective roles of iron and non-iron-related factors in 127 homozygous patients. J Hepatol 1992, 16:122-127.
107. LeSage GD, Baldus WP, Fairbanks VF, et al. Hemochromatosis: Genetic or alcohol-induced?. Gastroenterology 1983, 84:1471-1477.
108. Elzouki AN, Hulterantz R, Stal P, et al. Increased PiZ gene frequency for alpha 1 antitrypsin in patients with genetic haemochromatosis. Gut 1995, 26:922-926.
109. Angelucci E, Muretto P, Nicolucci A, et al. Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation. Blood 2002, 100:17-21.
110. Deugnier YM, Charalambous P, Le Quilleuc D, et al. Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: A study of 185 patients. Hepatology 1993, 18:1363-1369.
111. Terada T, Nakanuma Y Survey of iron accumulative macro-regenerative nodules in cirrhotic livers. Hepatology 1989, 10:851-854.
112. Elmes ME, Clarkson JP, Mahy NJ, Jasani B Metallothionein and copper in liver disease with copper retention-a histopathological study. J Pathol 1989, 158:131-137.
113. Hayashi H, Yano M, Fujita Y, Wakusawa S Compound overload of copper and iron in patients with Wilson's disease. Med Mol Morphol 2006, 39:121-126.
114. Pandit A, Bhave S Present interpretation of the role of copper in Indian childhood cirrhosis. Am J Clin Nutr 1996, 63:830S-835S.
115. Muller T, Feichtinger H, Berger H, Muller W Endemic Tyrolean infantile cirrhosis: An ecogenetic disorder. Lancet 1996, 347:877-880.
116. Bhusnurmath SR, Walia BN, Singh S, et al. Sequential histopathologic alterations in Indian childhood cirrhosis treated with ?-penicillamine. Hum Pathol 1991, 22:653-658.
117. Pradhan AM, Bhave SA, Joshi VV, et al. Reversal of Indian childhood cirrhosis by ?-penicillamine therapy. J Pediatr Gastroenterol Nutr 1995, 20:28-35.
118. Tanaka M, Wanless IR Pathology of the liver in Budd-Chiari syndrome: Portal vein thrombosis and the histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules. Hepatology 1998, 27:488-496.
119. Wanless IR, Liu JJ, Butany J Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis). Hepatology 1995, 21:1232-1237.
120. Petrelli M, Scheuer PJ Variation in subcapsular liver structure and its significance in the interpretation of wedge biopsies. J Clin Pathol 1967, 20:743-748.
121. Bedossa P, Dargere D, Paradis V Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003, 38:1449-1457.
122. Colloredo G, Guido M, Sonzogni A, Leandro G Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: The smaller the sample, the milder the disease. J Hepatol 2003, 39:239-244.
123. Abdi W, Millan JC, Mezey E Sampling variability on percutaneous liver biopsy. Arch Intern Med 1979, 139:667-669.
124. Nakamura T, Nakamura S, Aikawa T, et al. Morphological classification of liver cirrhosis based upon measurement of percent of interstitial tissue in liver biopsy specimens. Tohoku J Exp Med 1965, 87:110-122.
125. Muschmann RJ, Ryoo JW Hepatic structural correlates of liver fibrosis: A morphological analysis. Exp Mol Pathol 1989, 50:114-124.
126. Ryoo JW, Buschmann RJ Comparison of intralobar non-parenchyma, subcapsular non-parenchyma, and liver capsule thickness. J Clin Pathol 1989, 42:740-744.
127. Crawford AR, Lin XZ, Crawford JM The normal adult human liver biopsy: A quantitative reference standard. Hepatology 1998, 28:323-331.
128. Kutami R, Girgrah N, Wanless IR, et al. The Laennec grading system for assessment of hepatic fibrosis: Validation by correlation with wedged hepatic vein pressure and clinical features. Hepatology 2000, 32:407A.
129. Sawyerr AM, McCormick PA, Tennyson GS, et al. A comparison of transjugular and plugged-percutaneous liver biopsy in patients with impaired coagulation. J Hepatol 1993, 17:82-85.
130. Burroughs AK, Groszmann R, Bosch J, et al. Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: Is hepatic venous pressure gradient a better end point?. Gut 2002, 50:425-427.
131. Brunt EM Grading and staging the histopathological lesions of chronic hepatitis: The Knodell histology activity index and beyond. Hepatology 2000, 31:241-246.
132. Theise ND Liver biopsy assessment in chronic viral hepatitis: A personal practical approach. Mod Pathol 2007, 20(Suppl 1):S3-S14.
133. Wanless IR, Sweeney G, Dhillon AP, et al. Lack of progressive hepatic fibrosis during long-term therapy with deferiprone in subjects with transfusion-dependent beta-thalassemia. Blood 2002, 100:1566-1569.
134. Wanless IR, Bernier V, Seger M Intrahepatic portal sclerosis in patients without history of liver disease: An autopsy study. Am J Pathol 1982, 106:63-70.